| Variable |
Value |
| Age, years (IQR) |
33.5 (28-41.8) |
| Sex male, n (%) |
175 (75.4%) |
| Ethnic origin, n (%)
White
Hispanic
Asian
African |
168 (72.4%)
44 (19%)
3 (1.3%)
17 (7.3%) |
| Risk factor for HIV acquisition, n (%)
Heterosexual
Homosexual/bisexual
IDU
Other/Unknown |
101 (43.5%)
89 (38.4%)
35 (15.1%)
7 (3%) |
| HCV-coinfection, n (%) |
59 (25.4%) |
| HBV-coinfection, n (%) |
13 (5.6%) |
| Time since HIV diagnosis, months (IQR) |
14.6 (3.1-34.8) |
| Starting HAART year, n (%)
2004-2005
2006-2007
2008-2009 |
51 (22%)
82 (35.3%)
99 (42.6%) |
| CD4 cell count at HAART initiation, median cell/mm³ (IQR)
< 50, n (%)
50-199
200-349
≥ 350 |
229 (160-289)
21 (9.1%)
60 (25.9%)
128 (55.2%)
23 (9.9%) |
| Viral load (log10), median (IQR)
> 100.000 cop/ml, n (%) |
4.89 (4.34-5.38)
100 (43.1%) |
IDU, intravenous drug user; HCV, hepatitis C virus; HBV, hepatitis B virus;
HAART, high activity antiretroviral treatment |
